Questions discussed in this category
Will you use it rather than a carboplatin-containing regimen?
If ADT +/- ARPI + RT, what duration of systemic therapy do you recommend?
What imaging modality do you use (conventional, PSMA PET, etc.)? When do you image (ex: a PSA threshold or PSADT)?
When do you order PSMA PET? Do you preferably order Locametz (gallium Ga 68 gozetotide) PET?
Would you use it for initial staging or at time of biochemical recurrence?
Does patient age effect your approach?
Would you consider RPLND for any patients in light of the phase II SEMS trial presented at the 2021 ASCO GU Ca...
What line would you give pembrolizumab?
What neoadjuvant or adjuvant therapy would you give?
Ex: TKI alone, TKI + checkpoint inhibitor, checkpoint inhibitor alone, TKI + mTOR inhibitor. Please specify drug regimen, if applicable.
189871601416237160101557312423111341068393389726912087418445
Papers discussed in this category
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001-03-15
Clin Nutr, 2015 Aug 28
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-03-10
Clinical genitourinary cancer, 2018-12
J Urol, 2020 Apr
Lancet, 2020 Mar 05
Oncologist, 2020 Dec 03
J Urol, 2021 Feb 26
Nature reviews. Urology, 2018-04
JAMA Oncol,
Clin Cancer Res, 2019 Sep 11
Nat Rev Urol, 2021 Jan 11
N Engl J Med, 2020 Sep 18
J Clin Oncol, 2022 Aug 30
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-05-10
Eur Urol Oncol, 2022 May 20
J Clin Oncol, 2021 Dec 20